Literature DB >> 9183589

Skeletal muscle alterations in patients with chronic heart failure.

M Schaufelberger1, B O Eriksson, G Grimby, P Held, K Swedberg.   

Abstract

AIMS: To investigate skeletal muscle in patients with chronic heart failure and controls, and relate skeletal muscle variables to functional class, exercise capacity, central haemodynamics, muscle strength and medical treatment.
METHODS: Biopsy from the lateral vastus muscle was obtained in 43 patients and 20 controls. Right sided heart catheterization was performed in 19 patients and maximal exercise testing in 26 patients. In nine patients muscle strength was measured. Patients had higher lactate levels, higher lactate dehydrogenase activity, and lower oxidative enzymes activity than controls. In patients, the percentage of type I fibres and capillarization were decreased while the percentage of type II B fibres were increased. Lactate dehydrogenase activity correlated with exercise capacity, muscle strength and right atrial pressure. Digoxin-treated patients had significantly lower oxidative enzyme activity than patients without digoxin treatment.
CONCLUSION: Patients with chronic heart failure have several skeletal muscle abnormalities. Central haemodynamics and medical treatment may, in addition to inactivity, be important in skeletal muscle changes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183589     DOI: 10.1093/oxfordjournals.eurheartj.a015386

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

Review 1.  Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure.

Authors:  Holly R Middlekauff
Journal:  Circ Heart Fail       Date:  2010-07       Impact factor: 8.790

2.  Slow recovery of the impaired fatigue resistance in postunloading mouse soleus muscle corresponding to decreased mitochondrial function and a compensatory increase in type I slow fibers.

Authors:  Han-Zhong Feng; Xuequn Chen; Moh H Malek; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-07       Impact factor: 4.249

Review 3.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

Review 4.  Skeletal muscle inflammation and atrophy in heart failure.

Authors:  Kory J Lavine; Oscar L Sierra
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 5.  Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

Authors:  Bruno-Pierre Dubé; Pierantonio Laveneziana
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

6.  Myoglobin concentration in skeletal muscle fibers of chronic heart failure patients.

Authors:  Martijn A Bekedam; Brechje J van Beek-Harmsen; Willem van Mechelen; Anco Boonstra; Willem J van der Laarse
Journal:  J Appl Physiol (1985)       Date:  2009-08-06

Review 7.  Heart failure: a model of cardiac and skeletal muscle energetic failure.

Authors:  B Mettauer; J Zoll; A Garnier; R Ventura-Clapier
Journal:  Pflugers Arch       Date:  2006-06-10       Impact factor: 3.657

Review 8.  Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.

Authors:  Georgios Tzanis; Stavros Dimopoulos; Varvara Agapitou; Serafim Nanas
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 9.  Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.

Authors:  Daniel M Hirai; Timothy I Musch; David C Poole
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-28       Impact factor: 4.733

10.  Detection of calf muscle alterations in patients with chronic heart failure by P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise.

Authors:  Ichiro Nakae; Kenichi Mitsunami; Shinro Matsuo; Toshiro Inubushi; Shigehiro Morikawa; Terue Koh; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.